The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans

被引:14
|
作者
Bolton, Declan [1 ]
Marcos, Pilar [1 ]
机构
[1] Teagasc Food Res Ctr, Dublin D15 DY05, Ireland
关键词
Clostridioides difficile; ribotypes; environment; food; epidemiology; PCR-RIBOTYPE; 018; TOXINOTYPE-V; RETAIL MEAT; ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; POTENTIAL RESERVOIR; HIGH PREVALENCE; EASTERN REGION; POULTRY MEAT; RISK-FACTORS;
D O I
10.3390/foods12051094
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The recent discovery of the same Clostridioides difficile ribotypes associated with human infection in a broad range of environments, animals and foods, coupled with an ever-increasing rate of community-acquired infections, suggests this pathogen may be foodborne. The objective of this review was to examine the evidence supporting this hypothesis. A review of the literature found that forty-three different ribotypes, including six hypervirulent strains, have been detected in meat and vegetable food products, all of which carry the genes encoding pathogenesis. Of these, nine ribotypes (002, 003, 012, 014, 027, 029, 070, 078 and 126) have been isolated from patients with confirmed community-associated C. difficile infection (CDI). A meta-analysis of this data suggested there is a higher risk of exposure to all ribotypes when consuming shellfish or pork, with the latter being the main foodborne route for ribotypes 027 and 078, the hypervirulent strains that cause most human illnesses. Managing the risk of foodborne CDI is difficult as there are multiple routes of transmission from the farming and processing environment to humans. Moreover, the endospores are resistant to most physical and chemical treatments. The most effective current strategy is, therefore, to limit the use of broad-spectrum antibiotics while advising potentially vulnerable patients to avoid high-risk foods such as shellfish and pork.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Nurse Work Environment and Hospital-Onset Clostridioides difficile Infection
    Jung, Olivia S.
    Aiken, Linda H.
    Sloane, Douglas M.
    Fridkin, Scott K.
    Li, Yin
    Kang, Yu Jin
    Becker, Edmund R.
    Joski, Peter J.
    Cimiotti, Jeannie P.
    MEDICAL CARE, 2023, 61 (06) : 360 - 365
  • [22] Role of the Household Environment in Transmission of Clostridioides difficile Infection: A Scoping Review
    Egan, Catherine D.
    Sargeant, Jan M.
    Weese, J. Scott
    Jones-Bitton, Andria
    Zentner, Shawn E.
    JOURNAL OF ENVIRONMENTAL HEALTH, 2023, 85 (06) : 8 - 14
  • [23] Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
    Novakova, Elena
    Stofkova, Zuzana
    Sadlonova, Vladimira
    Hleba, Lukas
    ANTIBIOTICS-BASEL, 2021, 10 (09):
  • [24] Diverse Sources and Latent Reservoirs of Community-Associated Clostridioides difficile Infection
    Alshannaq, Ahmad F.
    Kates, Ashley E.
    Keating, Julie A.
    Mckinley, Linda L.
    Dixon, Jonah W.
    Safdar, Nasia
    CLINICAL INFECTIOUS DISEASES, 2024,
  • [25] Hepatitis E virus in humans, farm animals and animals from the sylvatic environment
    Bigoraj, Ewelina
    Rzeutika, Artur
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2017, 73 (08): : 456 - 461
  • [26] Humans and farm animals
    Rowan, AN
    ANTHROZOOS, 1996, 9 (2-3): : 70 - 71
  • [27] Opportunities for Nanomedicine in Clostridioides difficile Infection
    Wang, Pei-Wen
    Lee, Wei-Ting
    Wu, Ya-Na
    Shieh, Dar-Bin
    ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [28] Expert Commentary on Clostridioides difficile Infection
    Stewart, David B.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (02) : 156 - 156
  • [29] Clostridioides difficile infection: an emerging zoonosis?
    Tsai, Chin-Shiang
    Hung, Yuan-Pin
    Lee, Jen-Chieh
    Syue, Ling-Shan
    Hsueh, Po-Ren
    Ko, Wen-Chien
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (12) : 1543 - 1552
  • [30] Ridinilazole for the treatment of Clostridioides difficile infection
    Carlson, Travis J.
    Endres, Bradley T.
    Basseres, Eugenie
    Gonzales-Luna, Anne J.
    Garey, Kevin W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (04) : 303 - 310